Daniel Howard

As revenues fall, Golden Entertainment reports a net loss for 2025 while its CEO prepares to take the company private in a complex, multi-billion dollar deal.

The Illinois-based bank crushed Q4 estimates with a 62.5% profit jump, outperforming sector trends through strong interest income and strategic growth.

As Acorn preps its Q4 results, we look at the microcap's macro impact on grid reliability, cell towers, and the burgeoning smart energy market.

SCOA Real Estate Partners announces two major industrial projects, signaling a strategic push into high-demand logistics hubs in Charlotte and Minneapolis.

Atlanta's Ameris Bank leaps to #15 on Forbes' Best Banks list, the largest by assets in the top tier. What's behind its impressive growth?

The biopharma company shatters records with 51% growth in its key drug, ASCENIV, and outlines a strategic overhaul aimed at long-term market dominance.

A new oral drug shows remarkable success in healing stubborn herpes lesions in people with HIV, offering a much-needed breakthrough for a vulnerable population.

From UK sewage spills to global cholera outbreaks, aging infrastructure and climate change are fueling a surge in waterborne disease, prompting urgent calls for action.

After 100 years in a Vatican museum, a rare model dog sled returns to the Métis Nation, sparking a journey of cultural healing and reconciliation.

Backed by 1.2M citizens and 8 former world leaders, the 'My Voice, My Choice' initiative puts European democracy and reproductive rights at a crossroads.

The healthcare specialist reported a staggering 2025 net loss due to a write-down, but projects 30% revenue growth fueled by new contracts.

Novo Resources lands a C$5.8M capital injection to accelerate its high-potential gold exploration in the Pilbara and Victoria's Bendigo Zone.

Infortrend's new EonStor GS 5024U blends flash speed with massive HDD capacity, promising to cut petabyte-scale storage costs for AI and HPC.

Larimar Therapeutics' nomlabofusp receives Breakthrough Therapy Designation, paving an accelerated path for a potential disease-modifying treatment.

A new partnership brings hyper-local weather AI to snow removal, promising fewer slip-and-falls, smarter salt use, and ironclad liability protection.

At a key industry summit, Sutro Biopharma showcases its next-gen ADC platform, designed to overcome treatment resistance with "supercharged" dual-payload drugs.

Verrica Pharmaceuticals heads to a key investor conference with strong YCANTH sales, a promising pipeline for warts and skin cancer, and high expectations.

CTF Life and Kai Tak Sports Initiative's 'Fencing Plus' program is creating a new pathway for young athletes, turning community outreach into elite talent.

The biotech firm landed $1M at a premium, a sign of investor faith. But with past regulatory hurdles, can this cash pave a new path for its NurOwn® therapy?

A trio of franchise veterans has acquired WonderPlay Brands, aiming to rapidly scale its Kidcreate Studio art enrichment concept across the United States.